Real-World Evidence of Safety and Efficacy of Carboplatin plus Nanoparticle Albumin-Bound Paclitaxel in Patients with Advanced Non-Small-Cell Lung Cancer and Preexisting Interstitial Lung Disease: A Retrospective Study

Table 2

Toxicities.

Adverse events	All grades	Grade ≥3
	n (%)	n (%)
Hematological AEs
Leukopenia	9 (100)	3 (33.3)
Neutropenia	9 (100)	4 (44.4)
Anemia	6 (66.7)	5 (55.6)
Thrombocytopenia	5 (55.6)	3 (33.3)
Febrile neutropenia	0 (0)	0 (0)
Nonhematologic AEs
Alopecia	6 (66.7)	0 (0)
Anorexia	5 (55.6)	1 (11.1)
Lung infection	4 (44.4)	3 (33.3)
Fatigue	3 (33.3)	0 (0)
Sensory neuropathy	2 (22.2)	0 (0)
Nausea	1 (11.1)	0 (0)
Pneumonitis	0 (0)	0 (0)
Sepsis	0 (0)	0 (0)

AE: adverse event.